论文部分内容阅读
糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)是糖尿病(DN)的并发症之一,发病于DN早期,常累及感觉、自主及运动神经,并可引起其他并发症产生,如疼痛、感染、感觉缺失、难治性溃疡及创口难以愈合等,最终导致截肢。据有关资料统计,DPN的发生率为60%~90%,而我国住院糖尿病患者中DPN的发生率高达60.3%[1,2]。作者应用依帕司他治疗DPN 40例,并与单用西药治疗的40例进行对照观察,现报告如下。1资料与方法 1.1一般资料80例均来自2011年1月~2012年12月本院患者,随机分为治疗组和对照组各40例。其中治疗组男19例,女21例;年龄37~63岁,平均51岁;病程7个月~13年;
Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes mellitus (DN). It occurs in the early stage of DN and often affects sensory, autonomic and motor nerves and can cause other complications such as pain, infection, sensation Missing, refractory ulcers and wounds difficult to heal, eventually leading to amputation. According to statistics, the incidence of DPN is 60% to 90%, while the incidence of DPN in our hospitalized diabetic patients as high as 60.3% [1,2]. Author application of epalrestat 40 cases of DPN treatment, and with Western medicine treatment of 40 cases of controlled observation, are as follows. 1 Materials and Methods 1.1 General Information 80 cases were from January 2011 to December 2012 in our hospital were randomly divided into treatment group and control group of 40 cases. The treatment group, 19 males and 21 females; aged 37 to 63 years, mean 51 years; duration of 7 months to 13 years;